Shoenfeld Yehuda
Department of Medicine B, Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel.
J Autoimmun. 2007 Mar-May;28(2-3):165-9. doi: 10.1016/j.jaut.2007.02.012. Epub 2007 Mar 26.
Central Nervous System involvement in Systemic Lupus Erythematosus (CNS-SLE) is very common and ranges between 25%-70% of the patients. The CNS involvement is listed in the ARA criteria for SLE diagnosis. CNS-SLE is associated with more than 20 different autoantibodies. Yet, remarkable among them are the anti-P-ribosomal antibodies (anti-PR). These autoantibodies directed mainly against the carboxy 22 amino acids of the PO, P1 P2 ribosomal phosphoproteins. They are capable of penetrating lived cells and inducing apoptotic changes as well as leading to inhibition of specific cytokine secretion. The titer of the autoantibodies correlate with disease activity, kidney involvement and hepatitis. In this review, the mechanisms involved in CNS involvement and its relationship with anti-P ribosomal antibodies will be described.
系统性红斑狼疮(SLE)累及中枢神经系统(CNS-SLE)十分常见,在患者中的发生率为25% - 70%。中枢神经系统受累被列入SLE诊断的美国风湿病学会(ARA)标准中。CNS-SLE与20多种不同的自身抗体有关。其中,抗P-核糖体抗体(anti-PR)尤为突出。这些自身抗体主要针对PO、P1、P2核糖体磷蛋白的羧基端22个氨基酸。它们能够穿透活细胞,诱导凋亡变化,并导致特定细胞因子分泌受到抑制。自身抗体的滴度与疾病活动度、肾脏受累及肝炎相关。在本综述中,将描述中枢神经系统受累所涉及的机制及其与抗P核糖体抗体的关系。